Apigenin and hesperidin augment the toxic effect of doxorubicin against HepG2 cells
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Apigenin and hesperidin augment the toxic effect of doxorubicin against HepG2 cells
Authors
Keywords
-
Journal
BMC Pharmacology & Toxicology
Volume 20, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2019-05-03
DOI
10.1186/s40360-019-0301-2
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Apigenin, a dietary flavonoid, induces apoptosis, DNA damage, and oxidative stress in human breast cancer MCF-7 and MDA MB-231 cells
- (2018) Ivana Vrhovac Madunić et al. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
- Chemotherapeutic Drugs and Mitochondrial Dysfunction: Focus on Doxorubicin, Trastuzumab, and Sunitinib
- (2018) Stefania Gorini et al. Oxidative Medicine and Cellular Longevity
- Inhibition of sirtuins 1 and 2 impairs cell survival and migration and modulates the expression of P-glycoprotein and MRP3 in hepatocellular carcinoma cell lines
- (2018) María Paula Ceballos et al. TOXICOLOGY LETTERS
- Bioactive flavonoids in medicinal plants: Structure, activity and biological fate
- (2018) Tian-yang Wang et al. Asian Journal of Pharmaceutical Sciences
- Systemic Therapy for Hepatocellular Carcinoma: 2017 Update
- (2017) Masatoshi Kudo ONCOLOGY
- Combined Inhibitions of Glycolysis and AKT/autophagy Can Overcome Resistance to EGFR-targeted Therapy of Lung Cancer
- (2017) Mingtong Ye et al. Journal of Cancer
- Anticancer strategies based on the metabolic profile of tumor cells: therapeutic targeting of the Warburg effect
- (2016) Xi-sha Chen et al. ACTA PHARMACOLOGICA SINICA
- The Warburg effect: 80 years on
- (2016) Michelle Potter et al. BIOCHEMICAL SOCIETY TRANSACTIONS
- New insights and evolving role of pegylated liposomal doxorubicin in cancer therapy
- (2016) Alberto A. Gabizon et al. DRUG RESISTANCE UPDATES
- Lactate dehydrogenase inhibition: exploring possible applications beyond cancer treatment
- (2016) Giuseppina Di Stefano et al. Future Medicinal Chemistry
- Review on the binding of anticancer drug doxorubicin with DNA and tRNA: Structural models and antitumor activity
- (2016) D. Agudelo et al. JOURNAL OF PHOTOCHEMISTRY AND PHOTOBIOLOGY B-BIOLOGY
- Oxidative stress on cardiotoxicity after treatment with single and multiple doses of doxorubicin
- (2013) M Pacifico de Freitas Segredo et al. HUMAN & EXPERIMENTAL TOXICOLOGY
- Chemistry and Biological Activities of Flavonoids: An Overview
- (2013) Shashank Kumar et al. TheScientificWorldJOURNAL
- Apigenin induces DNA damage through the PKCδ-dependent activation of ATM and H2AX causing down-regulation of genes involved in cell cycle control and DNA repair
- (2012) Daniel Arango et al. BIOCHEMICAL PHARMACOLOGY
- Treatment of Hepatocellular Carcinoma: A Systematic Review
- (2012) Shibo Lin et al. Liver Cancer
- Antioxidant and prooxidant properties of flavonoids
- (2011) D. Procházková et al. FITOTERAPIA
- Spectrophotometric analysis of flavonoid-DNA interactions and DNA damaging/protecting and cytotoxic potential of flavonoids in human peripheral blood lymphocytes
- (2010) Gordana Rusak et al. CHEMICO-BIOLOGICAL INTERACTIONS
- Revisiting the Warburg effect in cancer cells with proteomics. The emergence of new approaches to diagnosis, prognosis and therapy
- (2010) Roberto Scatena et al. Proteomics Clinical Applications
- Reversal of the glycolytic phenotype by dichloroacetate inhibits metastatic breast cancer cell growth in vitro and in vivo
- (2009) Ramon C. Sun et al. BREAST CANCER RESEARCH AND TREATMENT
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now